Glaukos reports positive Phase 4 topline results for iDose TR with cataract surgery

Glaukos announced topline results from its Phase 4 trial evaluating iDose TR with cataract surgery in patients with open-angle glaucoma or ocular hypertension. The study met its primary efficacy endpoint, demonstrating statistically significant superiority and clinically meaningful IOP reduction versus cataract surgery alone.

Detected & updated continuously · Source: Nebula